Avanza Fonder’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Sell
27,365
-804
-3% -$386K 0.3% 63
2026
Q1
$13.8M Sell
28,169
-2,116
-7% -$1.15M 0.38% 49
2025
Q4
$17.5M Buy
30,285
+1,481
+5% +$838K 0.45% 40
2025
Q3
$14M Buy
28,804
+1,278
+5% +$595K 0.36% 45
2025
Q2
$11.2M Buy
27,526
+1,326
+5% +$554K 0.33% 53
2025
Q1
$12.8M Sell
26,200
-3,714
-12% -$2.01M 0.42% 42
2024
Q4
$15.6M Buy
+29,914
New +$16.4M 0.46% 30

Other funds holding TMO

Avanza Fonder's TMO Position: Q2 2026 in Review

Avanza Fonder reduced its Thermo Fisher Scientific (TMO) stake by 2.9% in Q2 2026, selling an estimated $386K and leaving 27,365 shares worth $13.7M. The position accounts for 0.3% of the portfolio, ranked #63.

Avanza Fonder first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $17.5M in Q4 2025. 954 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Avanza Fonder held 27,365 shares of Thermo Fisher Scientific worth $13.7M as of Q2 2026.
  • Avanza Fonder sold 804 Thermo Fisher Scientific shares in Q2 2026, an estimated $386K.
  • Thermo Fisher Scientific made up 0.3% of Avanza Fonder's portfolio in Q2 2026, its #63 holding.
  • Avanza Fonder first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's Thermo Fisher Scientific position peaked at $17.5M in Q4 2025.
  • 954 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.